Netherlands· NL-d4a4487b74b1

Paxlovid 150 mg filmomhulde tabletten (PF-12345678) en 100 mg filmomhulde tabletten (ritonavir)

A nirmatrelvir und ritonavir product containing nirmatrelvir + ritonavir, registered in Netherlands by Pfizer Europe MA EEIG. The same ATC class is registered in 11 of our 19 countries.

ATC J05AE30

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about nirmatrelvir + ritonavirAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Nirmatrelvir und ritonavir is registered in 11 of 19 countries.

Countries holding a registration under ATC J05AE30 (nirmatrelvir und ritonavir), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search nirmatrelvir und ritonavir products by name

Nirmatrelvir und ritonavir · ATC J05AE30

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of nirmatrelvir und ritonavir costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Nirmatrelvir und ritonavir · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

CH Switzerland$851.25

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: NIRMATRELVIR + RITONAVIR
Manufacturer: Pfizer Europe MA EEIG
Country: Netherlands (NL)
ATC code: J05AE30
ATC class: Nirmatrelvir und Ritonavir
Defined daily dose: 0.6 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
EU/1/22/1625

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for nirmatrelvir und ritonavir.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check nirmatrelvir und ritonavir against other medicines How interaction checks work

Nirmatrelvir und ritonavir · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Nirmatrelvir und ritonavir in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nirmatrelvir und ritonavir products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

Iceland · Paxlovid
Liechtenstein · Paxlovid
Norway · Paxlovid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/48d41f07-43ab-4611-bd32-36799cb1a5c9
GET /v1/drugs/48d41f07-43ab-4611-bd32-36799cb1a5c9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/paxlovid-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Nirmatrelvir and Ritonavir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp129406",
  "excipients": [
    "CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "COPOVIDON (E 1208)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "LACTOSE 1-WATER",
    "MACROGOL",
    "MACROGOL 3350",
    "MACROGOL 400",
    "NATRIUMSTEARYLFUMARAAT",
    "NATRIUMSTEARYLFUMARAAT",
    "POLYSORBAAT 80 (E 433)",
    "SILICIUMDIOXIDE (E 551)",
    "SILICIUMDIOXIDE (E 551)",
    "SORBITANMONOLAURAAT (E 493)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "NIRMATRELVIR",
    "RITONAVIR"
  ],
  "leaflet_url": null,
  "authorised_at": "2022/01/28",
  "procedure_number": "EMEA/H/C/005973",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/22/1625",
  "additional_monitoring": "Y"
}

API reference MCP server Plans

See everything about nirmatrelvir und ritonavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console